Loading peptide profile…
Loading peptide profile…
Healing Category
THE SYNAPSE ENHANCER
Neural Cell Adhesion Molecule-derived FGL peptide
This entry refers to the studied FGL(L), or FGLL, construct that mimics neural cell adhesion molecule. A phase 1 study assessed safety and blood levels in healthy men, not memory or dementia outcomes. It is not FDA approved.
Those with memory concerns · Researchers studying neuroplasticity · Students or professionals needing mental performance
Research dosing varies. No established human protocol
As needed for research
Not medical advice.
Based on what vendors sell, not a recommendation.
Injection
Sold as vials by 2 vendors
By mouth
Not sold by vendors we track
Nasal spray
Not sold by vendors we track
Not FDA approved, research use onlyHow we review these guides2 research sources
The study assessed 24 healthy men without a placebo group. It measured tolerability and blood levels, not cognitive treatment benefits.
Increases AMPA receptor availability for stronger connections
Protects neurons from damage and degeneration
No. This profile records FGL-L as not FDA approved and for research use only. Review the regulatory and source details on this page for the current context.
Dose: Research dosing varies. No established human protocol. Schedule: daily. Cycle: As needed for research. This is not a clinical recommendation and does not replace individualized instructions from a licensed clinician.
This guide links to 2 curated or current research sources. Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Review the FGL-L research sourcesReported side effects of FGL-L include Nasal burning and Watery eyes. They are reported or occasional reactions, not a prediction of what any one person will experience.
FGL-L has an editorial safety grade of B (Good Safety). A 24-man open-label study reported brief nasal burning and watery eyes, with no notable ECG or laboratory changes. This limited study does not establish long-term safety. Safety depends on dose, sourcing, health history and medical supervision, so this page does not call it safe for personal use.
In-stock prices from 2 vendors, checked Nov 10, 2026.
Market evidence
We found certificates from some of the FGL-L vendors we track. Based on the certificates our crawler found; vendors may publish more than we index. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves
ACTH-derived peptide approved in Russia, not approved by the FDA
from $1.33/mg · 249 vendorsNº 006 / 006Angiotensin IV-derived compound with no human studies
from $4/mg · 41 vendorsNº 002 / 006GDNF-derived peptide tested in rat brain and cell culture
Full profileNº 003 / 006A melanostatin tripeptide studied in depression research
Full profileNº 005 / 006Synthetic gastric peptide studied almost entirely in animals
from $1.70/mg · 392 vendorsNº 001 / 006Nine-amino-acid peptide with sparse, dated human studies
from $0.27/mg · 219 vendorsNº 004 / 006